Jim Cramer on Charles Schwab The Market May Be Misjudging the Brokerage Boston Omaha BOC Q4 2025 Results Miss Estimates EPS 023 vs 003 Fate Therapeutics FATE Q1 2026 Earnings Surprise EPS 026 Up Significant Summit Therapeutics SMMT Q1 2026 Results Miss Estimates EPS 024 vs 018 Nutrien Ltd NTR Holds Steady Above 70 on Modest Gains Key Resistance in Sight Iron Horse Acquisitions Rights IRHOR Slips Nearly 6 as Rights Trade Near Support Levels SEALSQ Corp LAES Bounces 533 as Bullish Momentum Builds Above 338 Support Inotiv Inc NOTV Continues Decline Testing Support Near 026